Prenatal HIV counseling, testing, and antiretroviral prophylaxis by obstetric and family medicine providers in Alabama

American Journal of the Medical Sciences

Volumn 324, Issue 6, 2002, Pages 305-309

  Nichols, Stacy A ^a   Bhatta, Madhav P ^a   Lewis, Jennifer ^a   Vermund, Sten H ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Alabama; Antiretroviral agents; Perinatal HIV transmission; Prevention

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; FAMILY MEDICINE; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; OBSTETRICS; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PRACTICE GUIDELINE; PREGNANCY; PRENATAL CARE; UNITED STATES; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0036948846     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200212000-00003     Document Type: Article

References (25)

1. Stoto MA, Almario DA, McCormick MC, editors. Reducing the odds: preventing perinatal transmission of HIV in the United States. Washington (DC): Institute of Medicine, National Academy Press; 1998. p. 397. Available at: URL: http:// www.nap.edu/books/0309062861/html/index.html
2. Conner EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331:1173-80.
3. Anonymous. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Recomm Rep 1994;43:1-20.
4. Anonymous. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep 1995;44: 1-15.
5. Centers for Disease Control and Prevention. Table 26, Estimated persons living with AIDS, by region of residence and year. In: HIV/AIDS surveillance report. 1999;11(2):37. Available at: URL: http://www.cdc.gov/hiv/stats/hasr1102.htm
6. Anonymous. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998;47:1-30.
7. Matheson PB, Abrams EJ, Thomas PA, et al. Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. J Infect Dis 1995;172: 353-8.
8. Anonymous. Human immunodeficiency virus screening. Joint statement of the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Pediatrics 1999;104:128.
9. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999;353:773-80.
10. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial. Lancet 1999;353:781-5.
11. Dabis F, Msellati P, Meda N, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet 1999;353:786-92.
12. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of human immunodeficiency virus. N Engl J Med 1998; 339:1409-14.
13. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
14. Centers for Disease Control and Prevention. Figure 5, Pediatric AIDS cases. In: HIV/AIDS surveillance report 2000; 12(2):26. Available at: URL: http://www.cdc.gov/hiv/stats/ hasr1202.htm
15. Centers for Disease Control and Prevention. Table 16, Pediatric HIV infection cases by exposure category and race/ ethnicity. In: HIV/AIDS surveillance report 1999;12(2):25. Available at: URL: http://www.cdc.gov/hiv/stats/hasr1202.htm
16. Centers for Disease Control and Prevention. Update on preventing perinatal transmission of HIV. Satellite broadcast, 1999 Apr 29. CDC Public Health Training Network (PHTN), CDC National Center for HIV, STD, and TB Prevention (NCHSTP), and the CDC National Prevention Information Network (NPIN). Transcript available at: URL: http:// www.cdcnpin.org/broadcast/past/1999/0429/Transcript.pdf
17. Thomas SB, Curran JW. Tuskegee: from science to conspiracy to metaphor. Am J Med Sci 1999;317:1-4.
18. Montaner JSG, Reiss P, Cooper D, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. JAMA 1998;270:930-7.
19. Stringer JSA, Vermund S. Prevention of mother-to-child transmission of HIV-1. Curr Opin Obstet Gynecol 1999;11: 427-34.
20. Rouse DJ, Owen J, Goldenberg RL, et al. Zidovudine for the prevention of vertical HIV transmission: a decision analytic approach. J Acquir Immun Defic Syndr Hum Retrovirol 1995;9:401-7.
21. Culnane M, Fowler M, Lee SS, et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 1999;281: 151-7.
22. Stringer JSA, Sinkala M, Rouse DJ, et al. Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health 2002;92:365-6.
23. Stringer JSA, Stringer EM, Phanuphak P, et al. Prevention of mother-to-child transmission of HIV in Thailand: physicians' attitudes on zidovudine use, pregnancy termination, and willingness to provide care. J Acquir Immune Defic Syndr 1999;21:217-22.
24. Bhatta MP, Stringer JSA, Phanuphak P, et al. Motherto-child HIV transmission prevention in Thailand: physician zidovudine use and willingness to provide care. Int J STD AIDS, in press.
25. Royce RA, Walter EB, Fernandez MI, et al. Barriers to universal prenatal HIV testing in 4 US locations in 1997. Am J Public Health 2001;91:727-33.